EP 1037618 A1 20000927 - USE OF NUCLEOSIDES, NUCLEOBASES AND THEIR DERIVATIVES FOR REDUCING THE THROMBOCYTOPENIC SIDE EFFECTS OF CYTOSTATIC AGENTS
Title (en)
USE OF NUCLEOSIDES, NUCLEOBASES AND THEIR DERIVATIVES FOR REDUCING THE THROMBOCYTOPENIC SIDE EFFECTS OF CYTOSTATIC AGENTS
Title (de)
VERWENDUNG VON NUCLEOSIDEN, NUCLEOBASEN UND DEREN DERIVATEN ZUM HERABSETZEN THROMBOCYTOPENISCHER NEBENWIRKUNGEN VON CYTOSTATIKA
Title (fr)
UTILISATION DE NUCLEOSIDES, DE NUCLEOBASES ET DE LEURS DERIVES POUR REDUIRE LES EFFETS SECONDAIRES THROMBOCYTOPENIQUES D'AGENTS CYTOSTATIQUES
Publication
Application
Priority
- DE 9902944 W 19990916
- DE 19842578 A 19980917
Abstract (en)
[origin: DE19842578A1] The use of nucleosides and nucleobases and their derivatives (I) is claimed for reducing thrombocytopenic side effects caused by cytostatic agents. The use of nucleosides and nucleobases and their derivatives of formula (I) is claimed for reducing thrombocytopenic side effects caused by cytostatic agents. R1 = OH or NH2; R2 = H or alkyl; R3 = H, alkyl or COOH; R4 = H or optionally substituted deoxyribosyl, ribosyl or arabinosyl.
IPC 1-7
IPC 8 full level
A61K 31/00 (2006.01); A61K 31/505 (2006.01); A61K 31/70 (2006.01)
CPC (source: EP)
A61K 31/7072 (2013.01)
Citation (search report)
See references of WO 0016753A2
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
DE 19842578 A1 20000323; EP 1037618 A1 20000927; WO 0016753 A2 20000330; WO 0016753 A3 20000914
DOCDB simple family (application)
DE 19842578 A 19980917; DE 9902944 W 19990916; EP 99969331 A 19990916